Us Bancorp \De\ Allogene Therapeutics, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 1,782 shares of ALLO stock, worth $4,045. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,782

Previous 1,570 13.5%

Holding current value

$4,045

Previous $3,000 33.33%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$2.08 - $3.5 $440 - $742	212 Added 13.5%	1,782 $4,000
Q2 2024 Aug 06, 2024	SELL	$2.23 - $4.38 $4,042 - $7,940	-1,813 Reduced 53.59%	1,570 $3,000
Q4 2023 Feb 09, 2024	BUY	$2.28 - $3.5 $1,883 - $2,891	826 Added 32.3%	3,383 $10,000
Q3 2023 Nov 03, 2023	BUY	$3.17 - $5.96 $2,723 - $5,119	859 Added 50.59%	2,557 $8,000
Q2 2023 Aug 09, 2023	BUY	$4.53 - $6.74 $5,481 - $8,155	1,210 Added 247.95%	1,698 $8,000
Q1 2023 May 09, 2023	SELL	$4.92 - $8.21 $13,982 - $23,332	-2,842 Reduced 85.35%	488 $2,000
Q4 2022 Feb 13, 2023	SELL	$5.62 - $11.11 $8,952 - $17,698	-1,593 Reduced 32.36%	3,330 $20,000
Q3 2022 Oct 27, 2022	SELL	$10.32 - $17.28 $5,686 - $9,521	-551 Reduced 10.07%	4,923 $54,000
Q2 2022 Aug 01, 2022	BUY	$6.78 - $12.28 $10,956 - $19,844	1,616 Added 41.89%	5,474 $63,000
Q1 2022 May 11, 2022	BUY	$7.65 - $15.29 $7,726 - $15,442	1,010 Added 35.46%	3,858 $35,000
Q4 2021 Feb 11, 2022	BUY	$13.13 - $24.52 $30,212 - $56,420	2,301 Added 420.66%	2,848 $42,000
Q3 2021 Nov 10, 2021	SELL	$21.01 - $27.64 $207,221 - $272,613	-9,863 Reduced 94.75%	547 $14,000
Q2 2021 Aug 05, 2021	BUY	$23.49 - $35.8 $986 - $1,503	42 Added 0.41%	10,410 $271,000
Q1 2021 Apr 28, 2021	BUY	$25.79 - $39.02 $259,731 - $392,970	10,071 Added 3390.91%	10,368 $366,000
Q4 2020 Feb 04, 2021	BUY	$25.24 - $43.45 $6,234 - $10,732	247 Added 494.0%	297 $7,000
Q3 2020 Nov 10, 2020	SELL	$32.38 - $44.96 $744 - $1,034	-23 Reduced 31.51%	50 $2,000
Q2 2020 Aug 07, 2020	BUY	$18.39 - $54.04 $422 - $1,242	23 Added 46.0%	73 $3,000
Q3 2019 Nov 08, 2019	BUY	$26.11 - $32.99 $1,305 - $1,649	50 New	50 $1,000

Others Institutions Holding ALLO

# of Institutions

162

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account